Moreover, the anti-oxidant activity of TRAP1 could contribute to cancer cell resistance to chemotherapeutics that elicit oxidative stress, especially in colorectal and breast cancer models (47, 82, 83). This evidence concerns the gene TRAP1 and cancer.